Premium
Aphasia, apraxia and neurogenic stuttering as complications of metrizamide myelography (Speech deficits following myelography)
Author(s) -
Pimental Patricia A.,
Gorelick Philip B.
Publication year - 1985
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1985.tb00905.x
Subject(s) - metrizamide , apraxia , clonazepam , myelography , aphasia , medicine , audiology , stuttering , psychology , anesthesia , psychiatry , spinal cord
– Aphasia following metrizamide myelography has been reported infrequently. During a seven‐month period, we examined two patients who developed Broca's aphasia, apraxia of speech, oral‐buccal‐facial apraxia and neurogenic stuttering after intrathecal metrizamide administration. In each case, focal neurologic deficits were accompanied by clinical, electroencephalographic and radiologic signs of generalized neurologic disease. Serial speech and language evaluations initially revealed severe deficits that were largely resolved by the third day post‐myelography. Out‐patient follow‐up examinations demonstrated persistence of mild speech and language abnormalities in each case. Our findings suggest that metrizamide may cause longlasting neurologic dysfunction.